| Electroconvulsive Therapy for Treatment of Alzheimer´s Disease (NCT02438202) | Central Institute of Mental Health, Mannheim | 2026-12-01 |
| A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence (NCT06845124) | Central Institute of Mental Health, Mannheim | 2025-07-22 |
| Brain Signal Training to Enhance Affect Down-regulation (NCT06626789) | Central Institute of Mental Health, Mannheim | 2025-04-23 |
| Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial (NCT06456983) | Central Institute of Mental Health, Mannheim | 2025-02-14 |
| Evaluation Study of New Compounds With Potential Use in Schizophrenia (NCT00916201) | Central Institute of Mental Health, Mannheim | 2025-01-31 |
| Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study (NCT02492074) | Central Institute of Mental Health, Mannheim | 2024-12-01 |
| Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder (NCT06959342) | Central Institute of Mental Health, Mannheim | 2024-09-23 |
| Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment (NCT06881810) | Central Institute of Mental Health, Mannheim | 2024-08-29 |
| Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation (NCT05726045) | Central Institute of Mental Health, Mannheim | 2024-04-01 |
| Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption (NCT06247306) | Central Institute of Mental Health, Mannheim | 2024-03-01 |
| Substance Consumption, Personality, and Cognitive Functioning of Chess Players (NCT06346353) | Central Institute of Mental Health, Mannheim | 2024-01-31 |
| Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder (NCT06105853) | Central Institute of Mental Health, Mannheim | 2023-12-01 |
| Chess Training as add-on Intervention for Adolescents With Psychiatric and Psychosomatic Disorders (NCT05698615) | Central Institute of Mental Health, Mannheim | 2022-10-01 |
| Does Depression Impact Our Memory for Rewarding Experiences (NCT05276583) | Central Institute of Mental Health, Mannheim | 2022-05-01 |
| Targeted Extinction of Drug Cues During Sleep - Olfactory Cue Reactivity Task (NCT05189379) | Central Institute of Mental Health, Mannheim | 2022-03-10 |
| Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder (NCT05093296) | Central Institute of Mental Health, Mannheim | 2021-12-02 |
| Adverse Childhood Experiences in Alcohol Use Disorder (NCT05048758) | Central Institute of Mental Health, Mannheim | 2021-11-22 |
| Modification of Cue Reactivity by Neurofeedback in Human Addiction (NCT04366505) | Central Institute of Mental Health, Mannheim | 2021-07-01 |
| Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression (NCT04670081) | Central Institute of Mental Health, Mannheim | 2021-06-10 |
| Evaluation of the Addictive Potential of E-Cigarettes (NCT04772014) | Central Institute of Mental Health, Mannheim | 2020-12-01 |
| Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia (NCT03911726) | Central Institute of Mental Health, Mannheim | 2020-08-01 |
| Neurobiological Mechanisms of Chess as an Add-On Treatment Against SUD (NCT04057534) | Central Institute of Mental Health, Mannheim | 2020-04-01 |
| Me and the Others: Expectations and Evaluation of Social Relationships (NCT03764566) | Central Institute of Mental Health, Mannheim | 2020-01-31 |
| Modification of Goal-directed and Habitual Behavior in Addiction (NCT03764969) | Central Institute of Mental Health, Mannheim | 2020-01-07 |
| Stress-related Predictor Profiles in Human Addiction (NCT03810924) | Central Institute of Mental Health, Mannheim | 2019-07-01 |
| Selective Attention in Alcohol Use Disorder (NCT03816527) | Central Institute of Mental Health, Mannheim | 2019-01-01 |
| Psychobiology of Stress and Alcohol Craving (NCT03810950) | Central Institute of Mental Health, Mannheim | 2019-01-01 |
| Adverse Childhood Experiences in Substance-related Disorders (NCT03758053) | Central Institute of Mental Health, Mannheim | 2018-12-15 |
| Cannabidiol - an in Vivo Innovative Drug Delivery Study (NCT03471559) | Central Institute of Mental Health, Mannheim | 2018-12-10 |
| Transcranial Direct Current Stimulation - Tobacco Use Disorder (NCT03691805) | Central Institute of Mental Health, Mannheim | 2018-10-15 |
| Validation of a Training Program for Patients With Alcohol Use Disorder (NCT03765476) | Central Institute of Mental Health, Mannheim | 2018-07-01 |
| Neurofeedback in Adolescents With Emotion Dysregulation (NCT03964545) | Central Institute of Mental Health, Mannheim | 2018-05-14 |
| Investigation of Brain Oxygenation and Blood Flow in Smokers (NCT03571243) | Central Institute of Mental Health, Mannheim | 2018-04-30 |
| Reversing Maladaptive Reorganization in Frail Brains (NCT03666039) | Central Institute of Mental Health, Mannheim | 2017-10-01 |
| Enhancing Recovery in Early Schizophrenia (NCT02926859) | Central Institute of Mental Health, Mannheim | 2017-04-08 |
| Training of Neural Responding in BPD (NCT02866110) | Central Institute of Mental Health, Mannheim | 2016-10-01 |
| A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients (NCT02088060) | Central Institute of Mental Health, Mannheim | 2015-12-08 |
| Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents (NCT02563145) | Central Institute of Mental Health, Mannheim | 2015-10-01 |
| Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents (NCT02485587) | Central Institute of Mental Health, Mannheim | 2015-09-01 |
| Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids (NCT02487381) | Central Institute of Mental Health, Mannheim | 2015-04-01 |
| Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity (NCT02372318) | Central Institute of Mental Health, Mannheim | 2015-04-01 |
| Effects of THC and CBD on Human Episodic Memory Function (NCT02291562) | Central Institute of Mental Health, Mannheim | 2014-07-01 |
| Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (NCT02291536) | Central Institute of Mental Health, Mannheim | 2014-02-01 |
| Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (NCT02051387) | Central Institute of Mental Health, Mannheim | 2013-01-01 |
| Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) (NCT01822418) | Central Institute of Mental Health, Mannheim | 2013-01-01 |
| Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain (NCT02157389) | Central Institute of Mental Health, Mannheim | 2012-07-01 |
| Neural and Pharmacological Correlates of Intrusions in Patients With Posttraumatic Stress Disorder (NCT01108133) | Central Institute of Mental Health, Mannheim | 2010-10-01 |
| The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes (NCT00926900) | Central Institute of Mental Health, Mannheim | 2009-03-01 |
| Hydrocortisone in the Treatment of Intrusions in Patients With Posttraumatic Stress Disorder (NCT01108146) | Central Institute of Mental Health, Mannheim | 2008-10-01 |
| Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine (NCT00938743) | Central Institute of Mental Health, Mannheim | 2008-01-01 |
| Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe PTSD Following Sexual Abuse (NCT00481000) | Central Institute of Mental Health, Mannheim | 2007-04-01 |
| Social Phobia Intervention Study of Mannheim (NCT00434759) | Central Institute of Mental Health, Mannheim | 2006-09-01 |
| Naltrexone in Borderline Personality Disorder (NCT00124839) | Central Institute of Mental Health, Mannheim | 2005-10-01 |
| Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine (NCT00224302) | Central Institute of Mental Health, Mannheim | 2005-08-01 |
| Validation in Humans of Genes Involved in Alcohol Drinking, Stress-Induced Alcohol Drinking and Relapse (NCT00326742) | Central Institute of Mental Health, Mannheim | 2005-07-01 |
| Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism (NCT01160991) | Central Institute of Mental Health, Mannheim | 2004-05-01 |
| Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial (NCT00224315) | Central Institute of Mental Health, Mannheim | 2003-11-01 |
| Individually Adapted Therapy of Alcoholism (NCT00317031) | Central Institute of Mental Health, Mannheim | 2002-11-01 |
| Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder (NCT01133301) | Central Institute of Mental Health, Mannheim | 1998-08-01 |
| Amitriptyline and Paroxetine Treatment of Major Depression (NCT01049347) | Central Institute of Mental Health, Mannheim | 1997-10-01 |